FDA Inspection 944539 — Symogen Inc.

Symogen Inc. — FEI 3011216918

The FDA completed an inspection of Symogen Inc. on Oct 2, 2015 in Woodbridge, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 2, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Woodbridge, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.